Lundbeck
HLUN-B.CO
#2981
Rank
C$5.60 B
Marketcap
$5.83
Share price
-3.57%
Change (1 day)
-9.87%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Annual Reports

Thumbnail Lundbeck
 Annual Report 2024

Annual Report 2024

Language: English

View Annual Report
Thumbnail Lundbeck
 Annual Report 2023

Annual Report 2023

Language: English

View Annual Report
Thumbnail Lundbeck
 Annual Report 2022

Annual Report 2022

Language: English

View Annual Report
Thumbnail Lundbeck
 Annual Report 2021

Annual Report 2021

Language: English

View Annual Report
Thumbnail Lundbeck
 Annual Report 2020

Annual Report 2020

Language: English

View Annual Report
Thumbnail Lundbeck
 Annual Report 2019

Annual Report 2019

Language: English

View Annual Report
Thumbnail Lundbeck
 Annual Report 2018

Annual Report 2018

Language: English

View Annual Report
Thumbnail Lundbeck
 Annual Report 2017

Annual Report 2017

Language: English

View Annual Report
Thumbnail Lundbeck
 Annual Report 2016

Annual Report 2016

Language: English

View Annual Report
Thumbnail Lundbeck
 Annual Report 2015

Annual Report 2015

Language: English

View Annual Report
Thumbnail Lundbeck
 Annual Report 2014

Annual Report 2014

Language: English

View Annual Report
Thumbnail Lundbeck
 Annual Report 2013

Annual Report 2013

Language: English

View Annual Report
Thumbnail Lundbeck
 Annual Report 2012

Annual Report 2012

Language: English

View Annual Report
Thumbnail Lundbeck
 Annual Report 2011

Annual Report 2011

Language: English

View Annual Report
Thumbnail Lundbeck
 Annual Report 2010

Annual Report 2010

Language: English

View Annual Report